Then, we confirmed that the overexpression of miR‐194‐3p could inhibit the proliferation, migration, and invasion of breast cancer cells and downregulate the protein level of MECP2, and the restoration of miR‐194‐3p expression could reduce the linc‐ROR‐mediated promotion of breast cancer progression. The gene discussed is MECP2; the disease is breast cancer.